Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture

Pharmaceutical Research

Volumn 25, Issue 4, 2008, Pages 969-978

  Konno, Hajime ^a,b   Taylor, Lynne S ^a  

^a PURDUE UNIVERSITY   (United States)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

Amorphous; Crystallization; FTIR; Solid dispersion; Water sorption

Indexed keywords

AQOAT; FELODIPINE; HYDROXYPROPYLMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE ACETATE SUCCINATE; PHARMACOAT; POVIDONE;

ARTICLE; CORRELATION ANALYSIS; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG COATING; DRUG STABILITY; DRUG STORAGE; GLASS TRANSITION TEMPERATURE; GRAVIMETRY; HUMIDITY; INFRARED SPECTROSCOPY; MICROSCOPY; MOISTURE; PHASE SEPARATION; PRIORITY JOURNAL; WATER ABSORPTION; WATER VAPOR; WETTABILITY;

ABSORPTION; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG STABILITY; FELODIPINE; HUMIDITY; KINETICS; METHYLCELLULOSE; MICROSCOPY, POLARIZATION; POLYMERS; POVIDONE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; TRANSITION TEMPERATURE; WATER; WETTABILITY;

EID: 43349097105     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9331-3     Document Type: Article

References (28)

1. W. L. Chiou and S. Riegelman. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60:1281-1302 (1971).
2. J. L. Ford. The current status of solid dispersions. Pharm. Acta Helv. 61:69-88 (1986).
3. A. T. M. Serajuddin. Solid dispersions of poorly water-soluble drugs: early promises, subsequent problems and recent breakthroughs. J. Pharm. Sci. 88:1058-1066 (1999).
4. C. Leuner and J. Dressman. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50:47-60 (2000).
5. M. Yoshioka, B. C. Hancock, and G. Zografi. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone). J. Pharm. Sci. 84:983-986 (1995).
6. L. S. Taylor and G. Zografi. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14:1691-1698 (1997).
7. T. Hino and J. L. Ford. Characterization of the hydroxypropylmethylcellulose-nicontinamide binary system. Int. J. Pharm. 219:39-49 (2001).
8. K. Yamashita, T. Nakate, K. Okimoto, A. Ohike, Y. Tokunaga, R. Ibuki, K. Higaki, and T. Kimura. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int. J. Pharm. 267:79-91 (2003).
9. T. Matsumoto and G. Zografi. Physical properties of solid dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl acetate) in relation to indomethacin crystallization. Pharm. Res. 16:1722-1728 (1999).
10. T. Miyazaki, S. Yoshioka, Y. Aso, and S. Kojima. Ability of poly(vinylpyrrolidone) and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen. J. Pharm. Sci. 93:2710-2717 (2004).
11. H. Konno and L. S. Taylor. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J. Pharm. Sci. 95:2692-2705 (2006).
12. G. Zografi. States of water associated with solids. Drug Dev. Ind. Pharm. 14:1905-1926 (1988).
13. C. Ahlneck and G. Zografi. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int. J. Pharm. 62:87-95 (1990).
14. S. L. Shamblin and G. Zografi. The effects of absorbed water on the properties of amorphous mixtures containing sucrose. Pharm. Res. 16:1119-1124 (1999).
15. C. A. Oksanen and G. Zografi. The relationship between the glass transition temperature and water vapor absorption by poly(vinylpyrrolidone). Pharm. Res. 7:654-657 (1990).
16. L. S. Taylor, F. W. Langkilde, and G. Zografi. Fourier transform Raman spectroscopic study of the interaction of water vapor with amorphous polymers. J. Pharm. Sci. 90:888-901 (2001).
17. V. Andronis and G. Zografi. Crystal nucleation and growth of indomethacin polymorphs from the amorphous state. J. Non-Cryst. Solids 271:236-248 (2000).
18. S. Inoue and R. Oldenbourg. Microscopes. Handbook of Optics, Volume II, Bass, M. (ed), McGraw-Hill, New York, 1995.
19. L. S. Taylor and G. Zografi. Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures. J. Pharm. Sci. 87:1615-1621 (1998).
20. B. C. Hancock and G. Zografi. Characteristics and significance of amorphous state in pharmaceutical systems. J. Pharm. Sci. 86:1-12 (1997).
21. B. Makower and W. C. Dye. Equilibrium moisture content and crystallization of amorphous sucrose and glucose. J. Agric. Food Chem. 4:72-77 (1956).
22. H. Imaizumi, N. Nambu and T. Nagai. Stability and several physical properties of amorphous and crystalline forms of indomethacin. Chem. Pharm. Bull. 28:2565-2569 (1980).
23. C. Schimitt, C. W. Davis, and S. T. Long. Moisture-dependent crystallization of amorphous lamotrigine mesylate. J. Pharm. Sci. 85:1215-1219 (1996).
24. V. Andronis, M. Yoshioka, and G. Zografi. Effects of sorbed water on the crystallization of indomethacin from the amorphous state. J. Pharm. Sci. 86:346-351 (1997).
25. F. Tanno, Y. Nishiyama, H. Kokubo and S. Obara. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions. Drug Dev. Ind. Pharm. 30:9-17 (2004).
26. A. Saleki-Gerhard and G. Zografi. Non-isothermal and isothermal crystallization of amorphous state. Pharm. Res. 11:1166-1173 (1994).
27. B. C. Hancock and G. Zografi. The relationship between glass transition temperature and water content of amorphous pharmaceutical solids. Pharm. Res. 11:471-477 (1994).
28. G. Van den Mooter, M. Wuyts, N. Blaton, R. Busson, P. Grobet, P. Augustijns, and R. Kinget. Physical stabi-lisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur. J. Pharm. Sci. 12:261-269 (2001).